Comparative Safety of Antiretroviral Treatment Regimens in Pregnancy. - Wikidata - awgldk - TriplyDB

Comparative Safety of Antiretroviral Treatment Regimens in Pregnancy.

Comparative Safety of Antiretroviral Treatment Regimens in Pregnancy.

http://www.wikidata.org/entity/Q38636802

about

Emulating a target trial of antiretroviral therapy regimens started before conception and risk of adverse birth outcomes.Poor Obstetric and Infant Outcomes in HIV-Infected Pregnant Women with Tuberculosis in South Africa: The Tshepiso Study.Altered angiogenesis as a common mechanism underlying preterm birth, small for gestational age, and stillbirth in women living with HIV.Influent factors of gestational vitamin D deficiency and its relation to an increased risk of preterm delivery in Chinese population.Effect of Gestational Age at Tenofovir-Emtricitabine-Efavirenz Initiation on Adverse Birth Outcomes in Botswana.Safety and pharmacokinetics of dolutegravir in HIV-positive pregnant women: a systematic review.Preterm delivery and small-for-gestation outcomes in HIV-infected pregnant women on antiretroviral therapy in rural South Africa: Results from a cohort study, 2010-2015.HIV antiretroviral exposure in pregnancy induces detrimental placenta vascular changes that are rescued by progesterone supplementation.Assessing the value of Western Cape Provincial Government health administrative data and electronic pharmacy records in ascertaining medicine use during pregnancy.Evaluating outcomes of mother-infant pairs using dolutegravir for HIV treatment during pregnancy

P2860

Q46290775-2DBB47BF-8EB3-4C3C-9496-C554DF05DFF8 Q46302162-533BA8B4-1402-44A1-9A34-47DA951BFCC2 Q47162116-32731041-CB0C-4FFE-9503-D592C61A85A6 Q50349733-8D9BB4B4-F54F-4B76-97A2-3687596273F3 Q52567195-F5F29E0C-7F8D-4BEF-8590-0392FD147D80 Q52571194-F41387AF-2E9F-4CCD-93D3-553E78B85AA0 Q53702903-8EB0703B-8F17-4D9E-B9D9-3BE2A0A37F1E Q55394797-65C62AAD-93D6-43A1-BE9D-F34A64540461 Q55515696-5A01FBE6-3531-4644-87E2-AED10A0CF7B3 Q58767934-06BCB2DD-308D-4B25-972B-1737BF07886B

P2860

Comparative Safety of Antiretroviral Treatment Regimens in Pregnancy.

http://www.wikidata.org/entity/Q38636802

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Comparative Safety of Antiretroviral Treatment Regimens in Pregnancy.

@en

type

label

Comparative Safety of Antiretroviral Treatment Regimens in Pregnancy.

@en

prefLabel

Comparative Safety of Antiretroviral Treatment Regimens in Pregnancy.

@en

P1433

Q38636802-BE34F644-FFE2-449D-BDC5-59B5B7798079

P1476

Q38636802-019F5D30-9F17-442F-A240-8A86734331DB

P2093

Q38636802-113FC900-1BBA-4636-969B-8AD0BF00A687

Q38636802-13F16142-9432-4CCB-816C-112FA23E7130

Q38636802-3DF6015E-EFA6-4F01-B928-9906D4222990

Q38636802-766F7FF4-2E95-4079-BBF9-9974ADDD8C83

Q38636802-80C8A787-3DB8-4A5C-A42D-4661067EC587

Q38636802-ACEE168D-4CA6-468E-A9AA-930C3B1670D8

Q38636802-BA6033A2-944F-4925-8DD2-9F3D8CC770CB

P2860

Q38636802-0F3394FD-B0CE-465F-9685-C8427C094C95

Q38636802-10C1B306-5D7F-4B69-8BD0-E42D989A381B

Q38636802-24FD3C36-FB66-4D49-BD07-329C47D7CAFF

Q38636802-27CD12D3-7C9D-4F74-BF5A-BA62A4E11ED6

Q38636802-2A73BE0D-ED06-4F10-8675-A3914AA26ABC

Q38636802-32EBB7D5-821F-4D20-9395-5FEE6FDCC6D2

Q38636802-3CD047ED-AA9A-4862-8A85-4E6BD353F6C6

Q38636802-41E6A995-0932-4AA2-A3A6-AEE9F8FF1173

Q38636802-4720EA8C-659B-40E0-B68D-4BD9C6FD7699

Q38636802-47EE7855-5345-436C-BA91-4CA1383F432E

P304

Q38636802-26D01793-D393-4D4A-99C2-D066628B4B4D

P31

Q38636802-C09FF81F-B543-4CD9-97A4-17DB778188FE

P356

Q38636802-8C9F378D-1E85-4477-9F9D-7EEE085295B4

P407

Q38636802-AB86A0C2-CA87-456F-9D98-6D2D16B2B46D

P50

Q38636802-6E9795A3-484B-474C-A552-DA8F8C265583

Q38636802-9DB1E7C9-E64A-4BF9-B01F-E7BD7348935E

Q38636802-A5599BC3-3160-42B6-9CB8-BCC1F96CA60D

P577

Q38636802-56604F0C-540D-437B-9F42-6E246FF2E3C1

P698

Q38636802-23F224EB-3D61-4D76-810F-EF777BFFF6AC

P921

Q38636802-29F0D33C-A410-4AE2-89AF-C830F831F82D

P932

Q38636802-9D996F34-CB80-4BD5-B5FD-528EB106A4BC

P356

JAMAPEDIATRICS.2017.2222

P1433

JAMA Pediatrics

P1476

Comparative Safety of Antiretroviral Treatment Regimens in Pregnancy.

@en

P2093

Chipo Petlo

http://www.w3.org/2001/XMLSchema#string

Denise L Jacobson

http://www.w3.org/2001/XMLSchema#string

Gloria Mayondi

http://www.w3.org/2001/XMLSchema#string

Modiegi Diseko

http://www.w3.org/2001/XMLSchema#string

Mompati Mmalane

http://www.w3.org/2001/XMLSchema#string

Rebecca Zash

http://www.w3.org/2001/XMLSchema#string

Roger L Shapiro

http://www.w3.org/2001/XMLSchema#string

P2860

Pregnancy outcome in women infected with HIV-1 receiving combination antiretroviral therapy before versus after conception

Cardiovascular disease risk factors in HIV-infected women after initiation of lopinavir/ritonavir- and nevirapine-based antiretroviral therapy in Sub-Saharan Africa: A5208 (OCTANE)

High prevalence of hypertension and placental insufficiency, but no in utero HIV transmission, among women on HAART with stillbirths in Botswana

Safety of efavirenz in the first trimester of pregnancy: an updated systematic review and meta-analysis.

Highly active antiretroviral therapy and adverse birth outcomes among HIV-infected women in Botswana.

4 million neonatal deaths: when? Where? Why?

Relationship between microbial translocation and endothelial function in HIV infected patients.

Stillbirths: rates, risk factors, and acceleration towards 2030.

Pregnancy outcomes in women exposed to efavirenz and nevirapine: an appraisal of the IeDEA West Africa and ANRS Databases, Abidjan, Côte d'Ivoire.

HIV protease inhibitor use during pregnancy is associated with decreased progesterone levels, suggesting a potential mechanism contributing to fetal growth restriction

P304

e172222

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/JAMAPEDIATRICS.2017.2222

http://www.w3.org/2001/XMLSchema#string

P407

P50

P577

2017-08-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28783807

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug

P932

5726309

http://www.w3.org/2001/XMLSchema#string